+44 (0) 1223 755950
+1 832 327 7413
orders@abbexa.com
Click on the image to see the image legend
Target | Peptidoglycan (Murein) |
Clonality | Monoclonal |
Reactivity | Bacteria |
Tested Applications | ELISA, IHC, IF/ICC |
Host | Mouse |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | Insoluble peptidoglycan obtained by TCA-heat and ethanol extraction of Streptococcus mutans BHT cells. |
Epitope Region | Appears to consist of discontinuous glycan and/or amino acid residues. |
Isotype | IgG1 |
Form | Liquid |
Purification | Unpurified ascites. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Validity | 12 months. |
Buffer | Does not contain preservatives. |
Specificity | Recognizes the 3D polymer complex structure of peptidoglycan. In a competitive immunoassay format, several compounds were found to be ineffective as inhibitors: muramyldipeptide, N-acetylglucosamine, chitin and acid hydrolyzed chitin. |
Concentration | Not determined. |
Availability | Shipped within 3-7 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Directions for use | When using this product in IHC-P, treatment with strong acid for Gram-positive bacteria, or with a detergent (such as SDS) for Gram-negative bacteria may be necessary to expose the epitope. |